Trial site
Kansas City Research Institute
- 9running trials
- 10closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)11 trials
- Liver cirrhosis5 trials
- Obesity2 trials
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastroparesis1 trial
- Hepatitis B1 trial
- High blood pressure1 trial
- Liver and biliary tract cancer1 trial
- Primary biliary cholangitis1 trial
- Type 2 diabetes1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 310 trials
- Phase 27 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed8 trials
- Active, not recruiting6 trials
- Recruiting3 trials
- Terminated2 trials
- Lead sponsor
- Madrigal Pharmaceuticals, Inc.3 trials
- Boehringer Ingelheim2 trials
- Gilead Sciences2 trials
- Novo Nordisk A/S2 trials
- Alfasigma S.p.A.1 trial
- and 9 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Active, not recruiting
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)3 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)
Terminated
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Site data: ClinicalTrials.govUpdated 13 Nov 2026